首页> 外国专利> Pharmaceutical preparations containing neurotrophic factors and gangliosides for treating nervous system pathologies

Pharmaceutical preparations containing neurotrophic factors and gangliosides for treating nervous system pathologies

机译:含有神经营养因子和神经节苷脂的药物制剂,用于治疗神经系统疾病

摘要

Provided is a pharmaceutical composition comprising at least one neurotrophic factor such as ciliary neurotrophic factor at a sub-threshold concentration ineffective in treating excitatory amino acid-induced neurotoxicity, and at least one ganglioside, ganglioside derivative, semisynthetic ganglioside analogue, or salt thereof such as GM1 or AGF2 at a sub-threshold concentration ineffective in treating excitatory amino acid-induced neurotoxicity. Such compositions can be prepared in the form of delivery vehicles such as microspheres, microcapsules, sponges, tubes, and guide channels comprising hyaluronic acid esters. These pharmaceutical compositions can be used in human and veterinary medicine to treat excitatory amino acid-induced neurotoxicity.
机译:提供了药物组合物,其包含在治疗兴奋性氨基酸诱导的神经毒性方面无效的亚阈值浓度的至少一种神经营养因子,例如睫状神经营养因子,和至少一种神经节苷脂,神经节苷脂衍生物,半合成神经节苷脂类似物或其盐,例如亚阈值浓度的GM1或AGF2在治疗兴奋性氨基酸诱导的神经毒性中无效。这样的组合物可以以递送载体的形式来制备,例如微球,微胶囊,海绵,管和包含透明质酸酯的引导通道。这些药物组合物可用于人类和兽医学,以治疗兴奋性氨基酸诱导的神经毒性。

著录项

  • 公开/公告号AU5336394A

    专利类型

  • 公开/公告日1994-05-24

    原文格式PDF

  • 申请/专利权人 FIDIA S.P.A.;

    申请/专利号AU19940053363

  • 发明设计人 STEPHEN DRAKE SKAPER;GINO TOFFANO;

    申请日1993-10-22

  • 分类号A61K37/02;A61K31/70;A61K31/725;

  • 国家 AU

  • 入库时间 2022-08-22 04:41:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号